While these biomarkers may not be relevant for all bladder cancer patients, elevated levels of β-hCG and CA125 in certain individuals can indicate potential metastatic disease or early progression of cancer that may not be detected through other diagnostic tests. Here, MUC16 is linked to urinary bladder cancer.